Spectrum Pharmaceuticals announces full enrollment of poziotinib EGFR cohort for previously treated NSCLC

Image: Spectrum Pharmaceuticals has announced full enrollment of poziotinib EGFR cohort for previously treated NSCLC. Photo: courtesy of renjith Krishnan / FreeDigitalPhotos.net.